13 analysts have expressed a variety of opinions on Elevance Health (NYSE:ELV) over the past quarter, offering a diverse set of opinions from bullish to bearish. The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective. Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $600.08, along with a high estimate of $643.00 and a low estimate of $530.00. A negative shift in sentiment…